Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Serological and virological analysis of maternal and fetal blood samples in prenatal human parvovirus b19 infection.

Weiffenbach J, Bald R, Gloning KP, Minderer S, Gärtner BC, Weidner A, Hanke M, Enders M.

J Infect Dis. 2012 Mar 1;205(5):782-8. doi: 10.1093/infdis/jir855. Epub 2012 Jan 24.

PMID:
22275404
2.

Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses.

de Haan TR, Beersma MF, Claas EC, Oepkes D, Kroes AC, Walther FJ.

Fetal Diagn Ther. 2007;22(1):55-62. Epub 2006 Sep 22.

PMID:
17003557
3.

Diagnostic and prognostic value of molecular and serological investigation of human parvovirus B19 infection during pregnancy.

Zavattoni M, Paolucci S, Sarasini A, Tassis B, Rustico M, Quarenghi A, Piralla A, Baldanti F.

New Microbiol. 2016 Jul;39(3):181-185. Epub 2016 Jun 10.

4.

Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique.

Török TJ, Wang QY, Gary GW Jr, Yang CF, Finch TM, Anderson LJ.

Clin Infect Dis. 1992 Jan;14(1):149-55.

PMID:
1571420
5.

[Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].

Stenner S, Enders G, Klee A, Eiden U, Weidner A, Gonser M.

Z Geburtshilfe Neonatol. 2002 May-Jun;206(3):102-6. German.

PMID:
12098826
6.

Human parvovirus B19: immunity of Greek females and prenatal investigation of hydrops fetalis.

Kyriazopoulou V, Simitsopoulou M, Bondis J, Diza E, Athanasiadis A, Frantzidou F, Souliou E.

Eur J Obstet Gynecol Reprod Biol. 1997 Aug;74(2):157-60.

PMID:
9306109
7.

Parvovirus B19 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters.

de Haan TR, Beersma MF, Oepkes D, de Jong EP, Kroes AC, Walther FJ.

Prenat Diagn. 2007 Jan;27(1):46-50.

PMID:
17154332
8.

Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.

Enders M, Weidner A, Rosenthal T, Baisch C, Hedman L, Söderlund-Venermo M, Hedman K.

J Infect Dis. 2008 Jan 1;197(1):58-62. doi: 10.1086/524302.

PMID:
18171285
9.

[NEW APPROACH IN DIAGNOSTIC ALGORITHM OF AN INFECTIOUS AGENTS (PARVOVIRUS B19 AND CHLAMYDIA TRACHOMATIS) INVOLVED IN THE DEVELOPMENT OF PATHOLOGICAL PREGNANCY].

Voleva S, Ivanova S, Marinov B, Genova-Kalou P, Manolov V, Vasilev V.

Akush Ginekol (Sofiia). 2016;55(3):30-9. Bulgarian.

PMID:
27514136
10.

Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops.

Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R.

J Clin Microbiol. 1996 Mar;34(3):603-8.

11.

Long term follow up of serostatus after maternofetal parvovirus B19 infection.

Dembinski J, Eis-Hübinger AM, Maar J, Schild R, Bartmann P.

Arch Dis Child. 2003 Mar;88(3):219-21.

12.

The lack of routine surveillance of Parvovirus B19 infection in pregnancy prevents an accurate understanding of this regular cause of fetal loss and the risks posed by occupational exposure.

Watt AP, Brown M, Pathiraja M, Anbazhagan A, Coyle PV.

J Med Microbiol. 2013 Jan;62(Pt 1):86-92. doi: 10.1099/jmm.0.046714-0. Epub 2012 Sep 13.

PMID:
22977072
13.

Infection and immunity for human parvovirus B19 in patients with febrile exanthema.

Pedranti MS, Barbero P, Wolff C, Ghietto LM, Zapata M, Adamo MP.

Epidemiol Infect. 2012 Mar;140(3):454-61. doi: 10.1017/S0950268811000823. Epub 2011 May 18.

PMID:
21676356
14.

The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.

Adam O, Makkawi T, Reber U, Kirberg H, Eis-Hübinger AM.

Epidemiol Infect. 2015 Jan;143(2):242-8. doi: 10.1017/S0950268814000600. Epub 2014 Mar 20.

PMID:
24650427
15.

Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.

Oh DJ, Lee YL, Kang JW, Kwon SY, Cho NS.

Korean J Lab Med. 2010 Feb;30(1):58-64. doi: 10.3343/kjlm.2010.30.1.58.

16.

The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis.

Yaegashi N, Okamura K, Yajima A, Murai C, Sugamura K.

J Perinat Med. 1994;22(2):159-63.

PMID:
7965545
17.

Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin.

Matsuda H, Sakaguchi K, Shibasaki T, Takahashi H, Kawakami Y, Furuya K.

J Perinat Med. 2005;33(6):561-3.

PMID:
16318623
18.

Atypical exanthems associated with Parvovirus B19 (B19V) infection in children and adults.

Drago F, Ciccarese G, Broccolo F, Javor S, Parodi A.

J Med Virol. 2015 Nov;87(11):1981-4. doi: 10.1002/jmv.24246. Epub 2015 May 12.

PMID:
25965702
19.

[Parvovirus B19 infection: the general aspects and gestational problems].

Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M.

Minerva Ginecol. 1995 Apr;47(4):121-5. Italian.

PMID:
7644092
20.

Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.

Juhl D, Görg S, Hennig H.

Vox Sang. 2014 Oct;107(3):226-32. doi: 10.1111/vox.12162. Epub 2014 Jun 11.

PMID:
24916600

Supplemental Content

Support Center